Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Gacci

Showing results (231-240 of 253) with videos related to

Pageof 26
Sort By:
Prostate Cancer and Prostatic Diseases|July 25, 2023
Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)Rossella Nicoletti, Andrea Alberti, Daniele Castellani, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Prostate Cancer and Prostatic Diseases|July 28, 2023
Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic reviewRossella Nicoletti, Andrea Alberti, Daniele Castellani, et al.
Human Reproduction (Oxford, England)|April 1, 2021
Reply: COVID-19: semen impairment may not be related to the virusMauro Gacci, Marco Coppi, Elisabetta Baldi, et al.
Journal of Clinical Medicine|July 9, 2022
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of <i>Serenoa repens</i> versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical StudyAntonio Alcaraz, David Castro-Díaz, Mauro Gacci, et al.
Urology|September 21, 2014
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimensTommaso Cai, Daniele Tiscione, Paolo Verze, et al.
International Urology and Nephrology|January 22, 2026
Accuracy, readability, and understandability of EAU guidelines bot for testicular cancerGiacomo Gallo, Riccardo Lombardo, Vincenzo Pagliarulo, et al.
Journal of Clinical Medicine|February 25, 2022
Efficacy and Safety of the Hexanic Extract of <i>Serenoa repens</i> vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical StudyAntonio Alcaraz, Mauro Gacci, Vincenzo Ficarra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2016
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional databaseRiccardo Schiavina, Lorenzo Bianchi, Marco Borghesi, et al.
Scientific Reports|January 21, 2026
Training and external validation of machine learning supervised prognostic models of upper tract urothelial cancer (UTUC) after nephroureterectomyRossella Nicoletti, Nick Ho, Hsiang-Ying Lee, et al.
Pageof 26

Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
Prostate Cancer and Prostatic Diseases|July 25, 2023
Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)Rossella Nicoletti, Andrea Alberti, Daniele Castellani, et al.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Prostate Cancer and Prostatic Diseases|July 28, 2023
Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic reviewRossella Nicoletti, Andrea Alberti, Daniele Castellani, et al.
Human Reproduction (Oxford, England)|April 1, 2021
Reply: COVID-19: semen impairment may not be related to the virusMauro Gacci, Marco Coppi, Elisabetta Baldi, et al.
Journal of Clinical Medicine|July 9, 2022
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of <i>Serenoa repens</i> versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical StudyAntonio Alcaraz, David Castro-Díaz, Mauro Gacci, et al.
Urology|September 21, 2014
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimensTommaso Cai, Daniele Tiscione, Paolo Verze, et al.
International Urology and Nephrology|January 22, 2026
Accuracy, readability, and understandability of EAU guidelines bot for testicular cancerGiacomo Gallo, Riccardo Lombardo, Vincenzo Pagliarulo, et al.
Journal of Clinical Medicine|February 25, 2022
Efficacy and Safety of the Hexanic Extract of <i>Serenoa repens</i> vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical StudyAntonio Alcaraz, Mauro Gacci, Vincenzo Ficarra, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2016
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional databaseRiccardo Schiavina, Lorenzo Bianchi, Marco Borghesi, et al.
Scientific Reports|January 21, 2026
Training and external validation of machine learning supervised prognostic models of upper tract urothelial cancer (UTUC) after nephroureterectomyRossella Nicoletti, Nick Ho, Hsiang-Ying Lee, et al.
Pageof 26